Talaris Therapeutics Inc

NASDAQ:TALS   4:00:00 PM EDT
1.45
+0.01 (+0.69%)
4:15:42 PM EDT: $1.45 0.00 (0.00%)
Earnings Announcements

Talaris Therapeutics Announces Q3 Financial Results

Published: 11/10/2022 12:47 GMT
Talaris Therapeutics Inc (TALS) - Talaris Therapeutics Announces Third Quarter Financial Results and Corporate Update.
Talaris Therapeutics Inc Q3 Loss per Share $0.46.
Talaris Therapeutics Inc - Qtrly Loss per Share $0.46.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.55

More details on our Analysts Page.